mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.3 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.3 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.3 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |